1. Home
  2. Labeler Index
  3. A-s Medication Solutions
  4. 50090-1597
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Gabapentin NDC 50090-1597 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

equation of Cockcroft and Gault - gabapentin fig1

equation of Cockcroft and Gault - gabapentin fig1

This text appears to be a formula or equation used in a medical or scientific context. It seems to be calculating something based on the individual's age and weight. The variable Lt is also mentioned, but its purpose is unclear without further information. The mention of creatinine suggests that this equation may be related to renal function or kidney health. However, due to the errors and lack of context, it is difficult to provide a more specific description.*

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig2

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig2

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig3

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig3

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 3 shows the proportion of responders in controlled studies on Postherpetic Neuralgia (PHN). The responders are patients who experienced a reduction in pain score of more than 50%. The y-axis represents the percentage of responders, ranging from 0% to 100%. The x-axis displays the different studies (Study 1 and Study 2). The graph indicates that Study 1 had a response rate of approximately 32%, while Study 2 had a response rate of roughly 29%. There are additional data points for different treatment groups (PBO, GBP 3600, GBP 1800, and GBP 2400) represented by bars with different heights. However, the exact values for these treatment groups are not readable.*

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Chemical Structure - gabapentin str

Chemical Structure - gabapentin str

Label Image - lbl500901072

Label Image - lbl500901072

This is a description for a product labeled "050-107". The product contains 90 capsules of Gabapentin, with a dosage strength of 480 mg. The Lot Number is indicated as "5981-0".*

Label Image - lbl500901597

Label Image - lbl500901597

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.